The Children's Investment Fund Foundation Report issue

Foundation

Organization Overview

First Clinical Trial
2017
NCT03079388
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Children's Investment Fund Foundation | The Children's Investment Fund Foundation

Active Ingredients

Drugs in Other Trials (2)

pyrimethamine (daraprim) (1 trial)

sulfadoxine (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2